Harmony Biosciences Holdings, Inc. Gross Profit 2019–2025
Harmony Biosciences Holdings, Inc. reported $670.11M of gross profit for fiscal 2025. That was 20.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +407.6%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $670.11M | 77.2% | +20.1% |
| FY 2024 | $557.92M | 78.1% | +21.1% |
| FY 2023 | $460.79M | 79.2% | +30.0% |
| FY 2022 | $354.37M | 80.9% | +41.8% |
| FY 2021 | $249.92M | 81.8% | +89.3% |
| FY 2020 | $132.00M | 82.6% | +2887.9% |
| FY 2019 | $4.42M | 73.7% | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $670.11M of gross profit for fiscal 2025. That was 20.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +407.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s gross profit?
Harmony Biosciences Holdings, Inc. (HRMY) reported gross profit of $670.11M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s gross profit changed over time?
Between fiscal 2019 and 2025, HRMY's gross profit grew at roughly 130.9% per year (compound annual rate), from $4.42M to $670.11M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.